Literature DB >> 8872366

Effects of class III antiarrhythmic drugs on the Na(+)-activated K+ channels in guinea-pig ventricular cells.

K Mori1, T Saito, Y Masuda, H Nakaya.   

Abstract

1. Class III antiarrhythmic drugs are known to block the outward currents through voltage-gated K+ channels. However, effects of class III antiarrhythmic drugs on the ligand-gated K+ channels have not been thoroughly examined. In this study effects of amiodarone and newer class III antiarrhythmic drugs, E-4031 and MS-551, on the Na+-activated K+ (KNa) current were examined in inside-out membrane patches and in whole cells isolated from guinea-pig ventricle. 2. The KNa channel current was activated by increasing [Na+]i from 0 mM to 30-100 mM with 150 mM [K+]o in inside-out membrane patches of ventricular myocytes. The channel current showed a larger slope conductance (210 pS), inward-going rectification and subconductance levels of various amplitudes. 3. E-4031 and MS-551 at high concentrations (300 microM) inhibited the K+ current by decreasing the open time (flickering block). On the other hand, amiodarone at relatively low concentrations (0.1-10 microM) inhibited the KNa channel current by decreasing the open probability rather than by decreasing the open time. The IC50 value of amiodarone for inhibiting the KNa channel current was 1.0 microM. 4. These drugs also inhibited the whole-cell outward current activated by intracellular loading of 50 mM [Na+]i and extracellular application of 10 microM ouabain. 5. These results indicate that class III antiarrhythmic drugs inhibit the KNa channel current in cardiac cells. However, there are sharp differences in the effective concentrations and the mode of inhibition between amiodarone and the newer class III antiarrhythmic drugs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8872366      PMCID: PMC1915750          DOI: 10.1111/j.1476-5381.1996.tb15686.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.

Authors:  M C Sanguinetti; N K Jurkiewicz
Journal:  J Gen Physiol       Date:  1990-07       Impact factor: 4.086

2.  Local anaesthetics transiently block currents through single acetylcholine-receptor channels.

Authors:  E Neher; J H Steinbach
Journal:  J Physiol       Date:  1978-04       Impact factor: 5.182

3.  Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells.

Authors:  A Fabiato; F Fabiato
Journal:  J Physiol (Paris)       Date:  1979

4.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

5.  Neutral carrier ion-selective microelectrodes for measurement of intracellular free calcium.

Authors:  R Y Tsien; T J Rink
Journal:  Biochim Biophys Acta       Date:  1980-07

6.  The effects of external cations and ouabain on the intracellular sodium activity of sheep heart Purkinje fibres.

Authors:  D Ellis
Journal:  J Physiol       Date:  1977-12       Impact factor: 5.182

7.  Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.

Authors:  L M Hondeghem; D J Snyders
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

8.  Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.

Authors:  H Katoh; S Ogawa; I Furuno; Y Sato; S Yoh; K Saeki; Y Nakamura
Journal:  J Pharmacol Exp Ther       Date:  1990-06       Impact factor: 4.030

9.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

10.  Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo.

Authors:  K P Anderson; R Walker; T Dustman; R L Lux; P R Ershler; R E Kates; P M Urie
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

View more
  6 in total

1.  Inhibitory effect of amiodarone on Na(+)/Ca(2+) exchange current in guinea-pig cardiac myocytes.

Authors:  Y Watanabe; J Kimura
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 2.  Anesthesia Protocols used to Create Ischemia Reperfusion Myocardial Infarcts in Swine.

Authors:  Ana Abad Cobo; Francisco M Sánchez Margallo; Claudia Báez Díaz; Virginia Blanco Blázquez; Irene González Bueno; Verónica Crisóstomo
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-07-24       Impact factor: 1.232

Review 3.  The Functional Properties, Physiological Roles, Channelopathy and Pharmacological Characteristics of the Slack (KCNT1) Channel.

Authors:  Qi Zhang; Ye Liu; Jie Xu; Yue Teng; Zhe Zhang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Cardiac Slo2.1 Is Required for Volatile Anesthetic Stimulation of K+ Transport and Anesthetic Preconditioning.

Authors:  Andrew P Wojtovich; C Owen Smith; William R Urciuoli; Yves T Wang; Xiao-Ming Xia; Paul S Brookes; Keith Nehrke
Journal:  Anesthesiology       Date:  2016-05       Impact factor: 7.892

5.  Slack, Slick and Sodium-Activated Potassium Channels.

Authors:  Leonard K Kaczmarek
Journal:  ISRN Neurosci       Date:  2013-04-18

6.  Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Zhihan Zhao; Huan Lan; Ibrahim El-Battrawy; Xin Li; Fanis Buljubasic; Katherine Sattler; Gökhan Yücel; Siegfried Lang; Malte Tiburcy; Wolfram-Hubertus Zimmermann; Lukas Cyganek; Jochen Utikal; Thomas Wieland; Martin Borggrefe; Xiao-Bo Zhou; Ibrahim Akin
Journal:  Stem Cells Int       Date:  2018-01-08       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.